ATE187888T1 - Zusammensetzungen und verfahren zur hemmung der leukozytenadhäsion an zns-myelin - Google Patents
Zusammensetzungen und verfahren zur hemmung der leukozytenadhäsion an zns-myelinInfo
- Publication number
- ATE187888T1 ATE187888T1 AT92915758T AT92915758T ATE187888T1 AT E187888 T1 ATE187888 T1 AT E187888T1 AT 92915758 T AT92915758 T AT 92915758T AT 92915758 T AT92915758 T AT 92915758T AT E187888 T1 ATE187888 T1 AT E187888T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- compositions
- leukocyte adhesion
- cns myelin
- inhibiting leukocyte
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/727,280 US5227369A (en) | 1991-07-11 | 1991-07-11 | Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
PCT/US1992/005836 WO1993000919A1 (en) | 1991-07-11 | 1992-07-13 | Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE187888T1 true ATE187888T1 (de) | 2000-01-15 |
Family
ID=24922037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92915758T ATE187888T1 (de) | 1991-07-11 | 1992-07-13 | Zusammensetzungen und verfahren zur hemmung der leukozytenadhäsion an zns-myelin |
Country Status (6)
Country | Link |
---|---|
US (1) | US5227369A (de) |
EP (1) | EP0593658B1 (de) |
JP (1) | JPH07505859A (de) |
AT (1) | ATE187888T1 (de) |
DE (1) | DE69230468D1 (de) |
WO (1) | WO1993000919A1 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2010321C (en) | 1989-02-21 | 2004-04-06 | Thomas F. Tedder | Lymphocyte-associated cell surface protein |
WO1994005314A1 (en) * | 1992-09-08 | 1994-03-17 | Centocor, Inc. | Peptide inhibitors of leukocyte adhesion |
US5753617A (en) * | 1992-09-08 | 1998-05-19 | Centocor, Inc. | Peptide inhibitors of cellular adhesion |
AU678469B2 (en) * | 1993-05-03 | 1997-05-29 | Genentech Inc. | Inhibition of leukocyte adhesion |
US5527785A (en) * | 1993-05-14 | 1996-06-18 | The Regents Of The University Of California | Selectin receptor modulating compositions |
US5856300A (en) * | 1994-05-12 | 1999-01-05 | T Cell Sciences, Inc. | Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
PT730608E (pt) | 1993-05-17 | 2002-09-30 | Avant Immunotherapeutics Inc | Composicoes compreendendo hidratos de carbono e proeinas relacionadas pelo complemento e metodos para produzir e utilizar as referidas composicoes |
US5976540A (en) * | 1993-05-17 | 1999-11-02 | T Cell Sciences, Inc. | Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
US5658880A (en) * | 1993-06-16 | 1997-08-19 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
US5750508A (en) * | 1993-06-16 | 1998-05-12 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
US5837689A (en) * | 1993-06-16 | 1998-11-17 | Glycomed Incorporated | Sialyl lewis-x mimetics containing naphthyl backbones |
US5789385A (en) * | 1993-06-16 | 1998-08-04 | Glycomed Incorporated | Sialyl Lewisx mimetics containing phenyl backbones |
US5679321A (en) * | 1993-06-17 | 1997-10-21 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
US5350748A (en) * | 1993-08-18 | 1994-09-27 | Warner-Lambert Company | 3-thio or amino substituted-benzo[b]thiophene-2-carboxamides and 3-oxygen, thio, or amino substituted-benzofuran-2-carboxamides as inhibitors of cell adhesion |
WO1995014787A1 (en) * | 1993-11-22 | 1995-06-01 | Centocor, Inc. | Peptide inhibitors of selecting binding |
US6884590B1 (en) | 1994-02-11 | 2005-04-26 | Cedars-Sinai Medical Center | Methods of screening for ulcerative colitis and crohn's disease |
US5681699A (en) * | 1994-02-11 | 1997-10-28 | Cedars-Sinai Medical Center | Methods of diagnosing ulcerative colitis and Crohn's disease |
US5672622A (en) * | 1994-04-21 | 1997-09-30 | Berlex Laboratories, Inc. | Treatment of multiple sclerosis |
US6060501A (en) * | 1994-06-02 | 2000-05-09 | Schering Aktiengesellschaft | Combined treatment of multiple sclerosis |
WO1996024350A1 (de) * | 1995-02-10 | 1996-08-15 | Schering Aktiengesellschaft | Pharmazeutische präparate zur tnf-inhibition |
US5876715A (en) * | 1995-08-17 | 1999-03-02 | The Biomembrane Institute | Antibodies that bind novel carbohydrate ligands (myelorollins) that cause E-selectin dependent cell rolling, and uses thereof |
DE19540475A1 (de) * | 1995-10-20 | 1997-04-24 | Schering Ag | Chirale Methylphenyloxazolidinone |
US6365365B1 (en) | 1998-03-20 | 2002-04-02 | The Regents Of The University Of California | Method of determining whether an agent modulates glycosyl sulfotransferase-3 |
US6265192B1 (en) | 1998-03-20 | 2001-07-24 | The Regents Of The University Of California | Glycosly sulfortransferase-3 |
US20050255098A1 (en) * | 2004-05-11 | 2005-11-17 | Rosen Steven D | Methods of treating traumatic spinal cord injury |
DE602005022924D1 (de) * | 2004-12-08 | 2010-09-23 | Cedars Sinai Medical Ct Los An | Verfahren zur diagnose von morbus crohn |
WO2008101133A2 (en) * | 2007-02-14 | 2008-08-21 | Cedars-Sinai Medical Center | Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease |
WO2008109782A2 (en) * | 2007-03-06 | 2008-09-12 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel disease in children |
US20100190162A1 (en) * | 2007-02-26 | 2010-07-29 | Cedars-Sinai Medical Center | Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease |
WO2010039931A2 (en) * | 2008-10-01 | 2010-04-08 | Cedars-Sinai Medical Center | Methods of using il17rd and il23-il17 pathway genes to diagnose crohn's disease |
WO2008116150A2 (en) | 2007-03-21 | 2008-09-25 | Cedars-Sinai Medical Center | Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease |
WO2008134569A2 (en) * | 2007-04-26 | 2008-11-06 | Cedars-Sinai Medical Center | Diagnosis and treatment of inflammatory bowel disease in the puerto rican population |
US20100144903A1 (en) * | 2007-05-04 | 2010-06-10 | Cedars-Sinai Medical Center | Methods of diagnosis and treatment of crohn's disease |
US20110189685A1 (en) * | 2008-10-22 | 2011-08-04 | Cedars-Sinai Medical Center | Methods of using jak3 genetic variants to diagnose and predict crohn's disease |
US20110229471A1 (en) * | 2008-11-26 | 2011-09-22 | Cedars-Sinai Medical Center | Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
WO2010075579A2 (en) | 2008-12-24 | 2010-07-01 | Cedars-Sinai Medical Center | Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy |
EP2978440B1 (de) | 2013-03-27 | 2019-10-02 | Cedars-Sinai Medical Center | Behandlung von fibrose durch tl1a-hemmung und diagnose von fibrose durch il31ra-nachweis |
WO2015010108A1 (en) | 2013-07-19 | 2015-01-22 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
US11186872B2 (en) | 2016-03-17 | 2021-11-30 | Cedars-Sinai Medical Center | Methods of diagnosing inflammatory bowel disease through RNASET2 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4294818A (en) * | 1979-07-30 | 1981-10-13 | University Patents, Inc. | Methods and materials for detection of multiple sclerosis |
EP0153875A3 (de) * | 1984-03-01 | 1987-06-24 | The State Of Victoria | Festphase-Enzymimmunanalyse und Testsatz |
US4708713A (en) * | 1984-11-16 | 1987-11-24 | Anisa Medical, Inc. | Method and system for removing immunosuppressive components from the blood of mammals |
US4839276A (en) * | 1984-12-05 | 1989-06-13 | Technicon Instruments Corporation | Interference - resistant liposome specific binding assay |
FR2574295B1 (fr) * | 1984-12-07 | 1988-02-26 | Rech Etu Therapeutiques | Medicaments a base de gluconate de zinc utiles pour le traitement des hyperprolactinemies |
US4752563A (en) * | 1985-11-19 | 1988-06-21 | Coulter Corporation | Monoclonal antibody for recovery of leukocytes in human peripheral blood and method of recovery employing said monoclonal antibody |
US4948726A (en) * | 1986-06-02 | 1990-08-14 | Longoria Claude C | Enzyme immunoassay based on membrane separation of antigen-antibody complexes |
US4935343A (en) * | 1986-08-08 | 1990-06-19 | Syntex (U.S.A.) Inc. | Monoclonal antibodies for interleukin-1β |
US4818686A (en) * | 1986-09-15 | 1989-04-04 | Coulter Corporation | Chemical blocking agent against non-specific binding or staining of an antibody specific for terminal deoxynucleotidyl transferase in biological specimens during immunoassay |
US5089479A (en) * | 1988-11-28 | 1992-02-18 | Krivan Howard C | Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
US4999375A (en) * | 1989-04-11 | 1991-03-12 | Hoffmann-La Roche Inc. | Psoralen reagent compositions for extracorporeal treatment of blood |
US4994466A (en) * | 1990-06-14 | 1991-02-19 | Baker Cummins Pharmaceuticals, Inc. | Method of treatment for multiple sclerosis |
-
1991
- 1991-07-11 US US07/727,280 patent/US5227369A/en not_active Expired - Lifetime
-
1992
- 1992-07-13 AT AT92915758T patent/ATE187888T1/de not_active IP Right Cessation
- 1992-07-13 JP JP5501815A patent/JPH07505859A/ja not_active Ceased
- 1992-07-13 WO PCT/US1992/005836 patent/WO1993000919A1/en active IP Right Grant
- 1992-07-13 DE DE69230468T patent/DE69230468D1/de not_active Expired - Lifetime
- 1992-07-13 EP EP92915758A patent/EP0593658B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1993000919A1 (en) | 1993-01-21 |
DE69230468D1 (de) | 2000-01-27 |
JPH07505859A (ja) | 1995-06-29 |
EP0593658A4 (de) | 1994-03-21 |
US5227369A (en) | 1993-07-13 |
EP0593658B1 (de) | 1999-12-22 |
EP0593658A1 (de) | 1994-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE187888T1 (de) | Zusammensetzungen und verfahren zur hemmung der leukozytenadhäsion an zns-myelin | |
DE69531753T2 (de) | Verbindungen zur Hemmung der Thrombin | |
DE69231281D1 (de) | Zusammensetzung und verfahren zur ulcusprävention und -behandlung | |
ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
DE3887875D1 (de) | Verfahren zur vorbeugung einer von blutplättchen abhängigen gefässthrombose. | |
DE69328497T2 (de) | Verfahren zur steigerung der wirksamkeit der futterverwertung bei tieren | |
BG101841A (en) | Cellular adhesion inhibitors | |
IL110031A (en) | Phenyl heterocycles their manufacture and pharmaceutical compositions containing them | |
DE69833779D1 (de) | Verfahren und zusammensetzungen zur immunomodulation | |
DE69232919D1 (de) | Verbindungen und Verfahren zur Inhibierung von HIV- und verwandten Viren | |
DE69331265T2 (de) | Verbindungen zur behandlung von entzündlichen erkrankungen und zur hemmung der produktion von tumornekrosefaktor | |
DE69431683T2 (de) | Verfahren zur Behandlung eines Polyolefingranulats | |
DE69533943D1 (de) | Vorrichtung zur durchführung von diagnostischen oder therapeutischen verfahren innerhalb der gallengänge | |
DE4192187T1 (de) | Verfahren zur Abtrennung vom Ilmenit | |
ATE384703T1 (de) | Piperazinyl-substituierte phenylpyrimidinderivative zur behandlung oder vorbeugung von zns erkrankungen | |
GR3026369T3 (en) | Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist. | |
BR9508732A (pt) | Métodos de inibição de desmielinação e de doenças desmielinativas | |
DE69429806T2 (de) | Pharmazeutische zusammensetzungen zur prävention und behandlung von krebserkrankungen und verfahren für ihre herstellung | |
ATE187336T1 (de) | Verwendung von interleukin-10 analogen oder antagonisten zur behandlung von endotoxin- oder superantigen induzierter toxizität | |
DE69122960D1 (de) | Verfahren und zubereitungen für die behandlung von verletzungen | |
DE69313411T2 (de) | Verfahren zur O-Alkylierung von phenolischen Verbindungen | |
DE69105823T2 (de) | Verfahren zur Behandlung von Metallmatrixverbundwerkstoffen. | |
DE69306869T2 (de) | Verfahren zur para-Hydroxyalkylierung von hydroxylierten aromatischen Verbindungen | |
DE50003730D1 (de) | Caspase 8-inhibitoren zur immunsuppression | |
DE59205760D1 (de) | Verfahren zur Herstellung N-substituierter Nitro-p-phenylendiamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |